The identification/selection of appropriate patient subgroups with asymptomatic carotid artery stenosis and the performance of prophylactic carotid endarterectomy (CEA)/carotid artery stenting (CAS) exclusively on these asymptomatic patient subgroups is currently one of the “hottest” topics in vascular surgery. It is now clear that offering CEA/CAS to asymptomatic carotid patients based only on the degree of carotid stenosis is unjustified and scientifically flawed. On the other hand, offering only best medical therapy to every asymptomatic patient, irrespective of certain high-risk criteria (such as the detection of microemboli by transcranial Doppler, intraplaque hemorrhage, silent embolic infarcts on brain computed tomography/magnetic resonance imaging, elevated biomarkers, family history), is equally wrong. The validation of specific measures to identify those asymptomatic patients at high risk for developing symptoms is crucial to achieve optimal use of carotid interventions and avoid wasting stroke prevention resources.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–1428.
2.
HallidayAMansfieldAMarroJ, et al; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–1502.
3.
HobsonRW IIWeissDGFieldsWS, et al.Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328(4):221–227.
4.
AbbottAL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10): e573–e583.
5.
ChaturvediS. Aggressive medical therapy alone is adequate in certain patients with severe symptomatic carotid stenosis. Stroke. 2013;44(10):2957–2958.
6.
NaylorAR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol. 2011;9(2):116–124.
7.
MarquardtLGeraghtyOCMehtaZRothwellPM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke. 2010;41(1): e11–e17.
8.
SpenceJDCoatesVLiH, et al.Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67(2):180–186.
9.
AbbottALParaskevasKIKakkosSK, et al.Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke. 2015;46(11):3288–3301.
10.
AbbottA. Asymptomatic carotid artery stenosis--it’s time to stop operating. Nat Clin Pract Neurol. 2008;4(1):4–5.
11.
EcksteinHHReiffTRinglebP, et al; SPACE 2 Investigators. SPACE-2: A Missed Opportunity to Compare Carotid Endarterectomy, Carotid Stenting, and Best Medical Treatment in Patients with Asymptomatic Carotid Stenoses. Eur J Vasc Endovasc Surg. 2016;51(6):761–765.
12.
LalBKMeschiaJFHowardGBrottTG. Carotid stenting versus carotid endarterectomy: what did the carotid revascularization endarterectomy versus stenting trial show and where do we go from here? [Published online August 9, 2106]Angiology. pii: 0003319716661661.
13.
ParaskevasKIMikhailidisDPVeithFJSpenceJD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology. 2016;67(5):411–419.
14.
ParaskevasKIKalmykovELNaylorAR. Stroke/death rates following carotid artery stenting and carotid endarterectomy in contemporary administrative dataset registries: a systematic review. Eur J Vasc Endovasc Surg. 2006;51(1):3–12.
15.
KallmayerMATsantilasPKnappichC, et al.Patient characteristics and outcomes of carotid endarterectomy and carotid artery stenting: analysis of the German mandatory national quality assurance registry - 2003 to 2014. J Cardiovasc Surg (Torino). 2015;56(6):827–836.
16.
KakkosSKNicolaidesANCharalambousI, et al; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg. 2014;59(4):956–967.
17.
KakkosSKNicolaidesANKyriacouE, et al.Computerized texture analysis of carotid plaque ultrasonic images can identify unstable plaques associated with ipsilateral neurologic symptoms. Angiology. 2011;62(4):317–328.
18.
KakkosSKGriffinMBNicolaidesAN, et al; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study. The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg. 2013;57(3):609–618.
19.
MarkusHSKingAShipleyM, et al.Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 2010;9(7):663–671.
20.
TopakianRKingAKwonSUSchaafsmaAShipleyMMarkusHSACESInvestigators. Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology. 2011;77(8):751–758.
SaccoRLKasnerSEBroderickJP, et al; American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089.
VoeksJHHowardGRoubinGS, et al; CREST Investigators. Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke.2011;42(12):3484–3490.
25.
YouTHSidaouiJMaroneLKMakarounMSChaerRA. Revascularization of asymptomatic carotid stenosis is not appropriate in patients on dialysis. J Vasc Surg. 2015;61(3):670–674.
26.
WallaertBCronenwettJLBertgesDJ, et al; Vascular Study Group of New England. Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg. 2013;58(1):112–118.
27.
WallaertJBDe MartinoRRFinlaysonSR, et al.Carotid endarterectomy in asymptomatic patients with limited life expectancy. Stroke. 2012;43(7):1781–1788.
ParlaniGDe RangoPCieriE, et al.Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy. J Vasc Surg. 2012;55(1):79–89.
30.
VikatmaaPMitchellDJensenLP, et al.Variation in clinical practice in carotid surgery in nine countries 2005-2010. Lessons from VASCUNET and recommendations for the future of national clinical audit. Eur J Vasc Endovasc Surg. 2012;44(1):11–17.
31.
ParaskevasKINaylorAR. External validation of randomized trial outcomes following carotid interventions in the modern era [Published online August 19, 2016]. Angiology. pii: 0003319716664267.
32.
LoftusIMParaskevasKIJohalA, et al.Editor’s Choice – Delays to Surgery and Procedural Risks Following Carotid Endarterectomy in the UK National Vascular Registry. Eur J Vasc Endovasc Surg. 2016;52(4):438–443.
33.
ParaskevasKISpenceJDVeithFJNicolaidesAN. Identifying which patients with asymptomatic carotid stenosis could benefit from intervention. Stroke. 2014;45(12):3720–3724.
34.
ParaskevasKIHamiltonGMikhailidisDP. Clinical significance of carotid bruits: an innocent finding or a useful warning sign?Neurol Res. 2008;30(5):523–530.
35.
PickettCAJacksonJLHemannBAAtwoodJE. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet. 2008;371(9624):1587–1594.
36.
GillettMDavisWAJacksonDBruceDGDavisTM; Fremantle Diabetes Study. Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: the Fremantle Diabetes Study. Stroke. 2003;34(9):2145–2151.
37.
BaronciniLAFilhoAPRamosSGMartinsARMurtaLOJr. Histological composition and progression of carotid plaque. Thromb J. 2007;5:4.
38.
GorguiJDoonanRJGomezYHKwongCDaskalopoulouSS. Carotid endarterectomy improves peripheral but not central arterial stiffness. Eur J Vasc Endovasc Surg. 2013;45(6):548–553.
39.
MarchionePVentoCMorrealeM, et al.Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study. J Stroke Cerebrovasc Dis. 2015;24(1):138–143.
40.
PetersSABotsMLLindLGroenewegenKAde KorteCden RuijterHM; METEOR study group. The impact of variability in ultrasound settings on the measured echolucency of the carotid intima-media. J Hypertens. 2013;31(9):1861–1867.
41.
LindLPetersSAden RuijterHM, et al; METEOR Study Group. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial. J Am Soc Echocardiogr. 2012;25(10):1120–1127.e1.
42.
Della-MorteDMoussaIElkindMSSaccoRLRundekT. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res. 2011;33(9):991–994.
43.
ParaskevasKIHamiltonGMikhailidisDP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007;46(2):373–386.
44.
NaylorAR. Lost in SPACE!Eur J Vasc Endovasc Surg. 2016;51(6):759–760.
45.
GiannopoulosAKakkosSAbbottA, et al.Long-term Mortality in Patients with Asymptomatic Carotid Stenosis: Implications for Statin Therapy. Eur J Vasc Endovasc Surg. 2015;50(5):573–582.
LiapisCDBellPFMikhailidisDP, et al; ESVS Guidelines Collaborators; European Society for Vascular Surgery. ESVS Guidelines: Section A--prevention in patients with carotid stenosis. Curr Vasc Pharmacol. 2010;8(5):673–681.
48.
LiapisCDBellPFMikhailidisDP, et al; ESVS Guidelines Collaborators; European Society for Vascular Surgery. ESVS Guidelines: Section B – diagnosis and investigation of patients with carotid stenosis. Curr Vasc Pharmacol. 2010;8(5):682–691.
